Mode of action of a diazoxide analog (A025). Its effects on insulin secretion.
D000311:Adrenal Glands / Q000502:physiology; D000818:Animals; D001322:Autoanalysis; D001786:Blood Glucose; D001794:Blood Pressure / Q000187:drug effects; D001806:Blood Urea Nitrogen; D002395:Catecholamines / Q000378:metabolism; D003981:Diazoxide / Q000008:administration & dosage / Q000494:pharmacology; D004285:Dogs; D005260:Female; D005951:Glucose Tolerance Test; D000882:Haplorhini; D006943:Hyperglycemia / Q000139:chemically induced* / Q000378:metabolism; D007004:Hypoglycemic Agents; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D008112:Liver Glycogen; D008297:Male; D051379:Mice; D010179:Pancreas / Q000187:drug effects*; D051381:Rats; D013997:Time Factors; D014044:Tolbutamide / Q000494:pharmacology
D001786:Blood Glucose; D002395:Catecholamines; D007004:Hypoglycemic Agents; D007328:Insulin; D008112:Liver Glycogen; D014044:Tolbutamide; D003981:Diazoxide